RECORNEA

medical devices

About

Recornea is a clinical-stage medtech ophthalmic company based in Trieste, Italy. Founded in 2019 and relocated from Singapore in 2020, the company specializes in developing innovative therapeutic solutions for eye diseases, particularly corneal shape deformations like keratoconus. Recornea is dedicated to preventing blindness by creating minimally invasive, biocompatible medical devices that restore the physiological shape of the cornea. The flagship product, the GROSSO® Implant, is designed to reshape the cornea in patients with pathological deformations, providing clear clinical outcomes and enhancing surgical procedures for ophthalmologists. Recornea is also developing an implantable filtering device for glaucoma, expanding its offerings in ophthalmology. The company has initiated clinical trials and holds multiple patents for its corneal implant technology, reflecting its commitment to innovation and quality in eye care.

Technologies

Outlook ASP.NET Bootstrap Framework Apache Google Tag Manager reCAPTCHA Mobile Friendly YouTube Microsoft-IIS Ubuntu Micro Render Remote Circle Octane AI

Keywords

medical equipment manufacturing shape-memory alloy implants medical devices us government grants niti4eye injector nitinol intracorneal implant minimally invasive ophthalmic devices regulatory approvals minimally invasive procedures healthcare equipment & supplies european clinical research medical equipment and supplies manufacturing corneal trauma treatment medical technology implantable eye devices european horizon 2020 first in human trial keratoconus treatment medical device development biotechnology implantable nitinol device grosso reshaper shape-memory materials corneal shape restoration innovation preclinical studies government minimally invasive surgery b2b bio-enhanced technology

Location

Trieste, Friuli-Venezia Giulia, Italy

Related Companies

Companies in the same industry